Sentences with phrase «by cancer of»

Equally uncommon is hypothyroidism in adult dogs caused by cancer of the thyroid gland.

Now I'm no longer plagued by the cancer of christianity.

Not exact matches

As Mary Mycio has pointed out in Slate, however, it's impossible to know how many incidents of cancer were directly caused by Chernobyl.

Drugmaker Merck reported a better - than - expected first - quarter profit on Tuesday, helped by a more than 150 percent rise in sales of cancer drug Keytruda.

That was followed by the takeover of Kairos Therapeutics, a Vancouver startup re-engineering human antibodies to fight cancer.

Perth - based law firm Jackson McDonald has honoured a former partner by funding an emerging cancer researcher as part of a record $ 4 million in grants announced by the Cancer Council WA cancer researcher as part of a record $ 4 million in grants announced by the Cancer Council WA Cancer Council WA today.

• Alliance HealthCare Services, which is owned by Tahoe Investment Group, agreed to acquire e + CancerCare, a Nashville, Tenn. - based provider of cancer care services.

Revenue from the cancer drug accounted for nearly 15 percent of Merck's total sales, helped by its expanded approval to treat various forms of cancer.

That was the eye - opening opening of a keynote address given yesterday by the brilliant John Quackenbush, a professor of biostatistics and computational biology at Dana - Farber Cancer Institute who has a dual professorship at the Harvard T.H. Chan School of Public Health and ample other academic credits after his name.

But with the exception (perhaps) of some infections, human disease, including lung cancer, is rarely «caused» by one (and only one) thing.

There are more than 80 immune - related cancer therapies currently in clinical trials, fueled by many billions of dollars in pharmaceutical investment from the likes of Bristol - Myers Squibb bmy, Merck mrk, Pfizer pfe, and dozens of biotechs.

PICI (pronounced «pie - sea»), as it's called by its member scientists, is doing something unprecedented in academic medicine: combining and coordinating the efforts of six of the top cancer immunology centers in the country — MD Anderson Cancer Center, Memorial Sloan Kettering, Penn Medicine, Stanford, UCLA, and UCSF — in order to greatly expand and, more important, to accelerate our understanding of why some immune - based treatments work miraculously in some patients and not at all in ocancer immunology centers in the country — MD Anderson Cancer Center, Memorial Sloan Kettering, Penn Medicine, Stanford, UCLA, and UCSF — in order to greatly expand and, more important, to accelerate our understanding of why some immune - based treatments work miraculously in some patients and not at all in oCancer Center, Memorial Sloan Kettering, Penn Medicine, Stanford, UCLA, and UCSF — in order to greatly expand and, more important, to accelerate our understanding of why some immune - based treatments work miraculously in some patients and not at all in others.

A panel of three entrepreneurs discussed the relationship between purpose and profitability in greater depth: Pocket Sun, who, as founding partner of female - focused VC firm SoGal Ventures, has a purpose of «building an empire for millennial women to invest in startups»; Eileen Gittins, a serial entrepreneur who founded book self - publishing firm Blurb and now runs Bossygrl, a mobile app meant to introduce Gen Z girls to entrepreneurship by helping them launch micro-businesses; and Cathie Reid, co-founder and current digital advisor to Icon Group, an Australian cancer - care company with annual revenue of more than $ 1.5 billion.

And that, at long last, brings me to a truly important editorial written by several members of the board of directors of the new Biden Cancer Initiative — which we ran on Fortune.com this morning.

Of 12 major, large - cap biopharmaceutical companies examined by Deloitte, the industry appears to be homing in on cancer therapies — and for a good economic reason.

Then Yee and Parker, a pair of crutches by his side, took a limo to a Sony Pictures sne studio in Culver City, where a televised fundraiser, Stand Up to Cancer, was being recorded that evening.

As I've said, there have been a number of research papers of late, led in large part by the work of French scientist Laurence Zitvogel, that are building a strong case for a central role for the microbiome in cancer treatment response.

Montreal's Gemin X Biotechnologies closed a US$ 65.2 - million private financing deal, one of the largest ever by a non-listed Canadian biotech, in May 2005, to develop and market its enzyme inhibitors against cancer.

Martin Shkreli, unaffectionately known as the «pharma bro» — and infamous for his decision to hike the list price of Daraprim, a drug used by HIV / AIDS and cancer patients to combat infections, by more than 5,000 % in 2015 under his former company Turing Pharmaceuticals — was convicted on three criminal securities fraud and conspiracy charges by a Brooklyn jury on Friday.

• Aileron Therapeutics, a cancer treatment biotech based out of Cambridge, Mass., said it plans to offer 3.75 million shares between $ 15 to $ 17, raising about $ 60 million at the offering's midpoint — about $ 25 million of which will be bought by insiders.

Research highlighted by the National Cancer Institute suggests that the more alcohol you drink — particularly the more you drink regularly — the higher your risk of developing cCancer Institute suggests that the more alcohol you drink — particularly the more you drink regularly — the higher your risk of developing cancercancer.

Printed materials can be used to replace bones: A woman in the Netherlands had much of her skull replaced by a printed plastic one, and a cancer patient in Spain received a printed titanium rib cage.

That research will be crucial: An earlier effort by another company, Pathway Genomics, to create a «liquid biopsy» for cancer was greeted in September by a stern letter from the Food and Drug Administration (FDA) warning that the agency had «not found any published evidence that this test or any similar test has been clinically validated as a screening tool for early detection of cancer in high risk individuals.»

The firm is already helping a variety of major cancer centers with its tech; the new worker benefit program will allow employees to consult with their doctors by giving them their medical history and getting their specific cancers genetically sequenced.

Johnson & Johnson's cancer treatment Zytiga significantly cut the death risk for newly - diagnosed, advanced prostate cancer patients by 38 %, according to data unveiled at the ongoing American Society of Clinical Oncology (ASCO) annual meeting this weekend.

But in medicine, impressive technology is little more than a parlor trick if it doesn't benefit patients — like James (who asked to keep his last name private), a 42 - year - old colon cancer patient who had part of his large intestine removed by Sullivan a few months ago.

Good news: Deaths from cancer and heart disease — by far the two biggest killers of Americans — are on the decline, according to a new report from the Centers for Disease Control and Prevention (CDC), as are those related to HIV.

Now a new clinical trial is under way, by New York's Mount Sinai, to test a vaccine to combat recurrence in some of the most deadly forms of cancer, including lung, breast, gynecological and bladder cancers.

The company is selling a thing (the kit) by saying it can provide «health reports on 254 diseases and conditions,» including categories such as «carrier status,» «health risks,» and «drug response,» and specifically as a «first step in prevention» that enables users to «take steps toward mitigating serious diseases» such as diabetes, coronary heart disease, and breast cancer...» Most of the uses «listed on your website, a list that has grown over time,» the FDA writes, «are medical device uses [for the] Personal Genome Service.»

The matter was investigated by Alberta Health Services, the Alberta College of Physicians and Surgeons and Health Canada, all of which concluded the incidence of cancer was not out of the range of normal probability and there was no indication industrial activity had increased the contaminants in the water above naturally occurring levels.

Within weeks of his appointment, Bell was diagnosed with cancer, left the company by November, and died in January 2005.

According to the American Cancer Society, cancer is the second most common cause of death in the United States, exceeded only by heart diCancer Society, cancer is the second most common cause of death in the United States, exceeded only by heart dicancer is the second most common cause of death in the United States, exceeded only by heart disease.

Many of us were shaken by the news that Beau Biden, son of Vice President Joe Biden, had died of brain cancer.

This drug has already staked its claim in the world of next - gen «checkpoint inhibitor» cancer treatments by besting rival Bristol - Myers Squibb's competing treatment Opdivo in advanced non-small cell lung cancer (NSCLC).

The first step in the process is to surgically remove the patient's tumor and ensure that the patient is cancer free by confirming that there is no sign of cancer on blood tests and imaging studies.

Immune cells modified by CRISPR - Cas9 were inserted into a lung cancer patient at the West China Hospital in Chengdu in the hopes that they'll be able to fight tumors, and 10 people total will receive injections of CRISPR re-engineered cells in order to assess the method's safety.

He was helped in the realization by remembering a close friend who had died of pancreatic cancer the year before.

A big part of what's driving Opdivo's success is an early decision by BMS to chase a much wider share of the cancer patient population — a decision that has meant that doctors don't have to administer a time - consuming diagnostic test to check if patients have a protein called PD - L1 before prescribing Opdivo in certain cancers.

A series of cancer research projects led by the University of Western Australia has been awarded $ 18 million from the Cancer Research Trust and other partner organisacancer research projects led by the University of Western Australia has been awarded $ 18 million from the Cancer Research Trust and other partner organisaCancer Research Trust and other partner organisations.

Investors can participate in the potential of companies such as TIO Networks Corp. (TSXV: TNC), an expedited bill - payment processor, which recorded $ 36.5 million in revenues in 2011, an increase of almost 50 % over the previous year, and Verisante Technology Inc. (TSXV: VRS), a medical device company that commercializes cancer detection systems using a platform developed by the BC Cancer Acancer detection systems using a platform developed by the BC Cancer ACancer Agency.

When placed at the site of a cancerous tumour in a rodent and «activated» by a scope with a light source, the compounds eradicated up to 100 % of cancer cells.

Other studies, meanwhile, are examining tryp's potential efficacy as an antifungal agent; and as a prognostic indicator in patients with brain cancer (as seen by increased uptake of the amino acid on a PET scan).

Some of this is fueled by anxious patients, some by doctors who know that missing a cancer diagnosis can be grounds for a medical malpractice lawsuit.

By then, the economic burden of brain health will be higher than those of cancer, diabetes and respiratory conditions combined.

We managed to stop putting a hole in the ozone layer by phasing out the chemicals that were causing it (cholofluorocarbons) and, as a result, the hole is closing and there are millions fewer cases of skin cancer than there would otherwise have been.

Using an app created by a company called Medical Realities, viewers from around the globe, each presumably with an iron constitution, witnessed a surgeon at the Royal London NHS Hospital delve into the bowels of a 70 - year - old cancer patient.

An enterprise version of its software has been adopted by the National Cancer Institute and by four of the world's largest pharmaceutical companies.

But Verisante Technology Inc. of Richmond, B.C., had reason to celebrate recently when its Verisante Aura, a device that detects melanoma and other cancers in a quick and non-invasive way, was approved for sale by Health Canada.

Right now such cancers are usually confirmed by way of a biopsy — a doctor literally removes tissue and sends it to a lab for analysis, which can take days.

According to the GAO report, 71 percent of all generic injectable cancer drugs sold in 2008 were produced by just three manufacturers, while 91 percent of the market share of injectable nutrients and supplements was held by just three pharmaceutical firms.